High-Flow oxygen may shield lungs after keyhole surgery

NCT ID NCT07676760

Not yet recruiting Knowledge-focused Sponsor: Bursa Yuksek Ihtisas Training and Research Hospital Source: ClinicalTrials.gov ↗

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This study investigates whether high-flow nasal cannula (HFNC) oxygen therapy can reduce lung collapse (atelectasis) after laparoscopic surgery. About 90 adults undergoing elective laparoscopic procedures will receive either HFNC or standard oxygen after breathing tube removal. Doctors will use lung ultrasound to compare lung health between the two groups. The goal is to see if HFNC helps keep lungs open and lowers the risk of breathing problems after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: High-Flow Nasal Cannula (HFNC) oxygen therapy
What this could lead to: If effective, HFNC could become a standard way to prevent lung collapse after laparoscopic surgery, reducing breathing complications.
What could go wrong: This is a small observational study, not a large trial. Results may not apply to all patients, and HFNC might not significantly reduce atelectasis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTOPERATIVE ATELECTASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pneumoperitoneum

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POSTOPERATIVE ATELECTASIS POSTOPERATIVE PULMONARY COMPLICATIONS

More trials for these conditions

Other studies related to the condition(s) this trial covers.